Publication | Closed Access
Adjuvant <i>vs.</i> neoadjuvant radiochemotherapy for locally advanced rectal cancer: the German trial CAO/ARO/AIO‐94
216
Citations
28
References
2003
Year
The patient accrual to the trial is satisfactory. Neoadjuvant RCT is well tolerated and bears no higher risk for postoperative morbidity.
| Year | Citations | |
|---|---|---|
Page 1
Page 1